Authors: Harrison L, Melvin A, Fiscus S, et al. For PENPACT-1 (PENTA 9PACTG 390) Study Team. Published in: JAIDS 2015;70(1):42-53 Background The PENPACT-1 trial compared virologic thresholds to determine when to switch…
Authors: Yin D., Warshaw M., Miller W., Castro H., Fiscus S., Harper L., Harrison L., Klein N., Lewis J., Melvin A., Tudor-Williams G., McKinney R. Published in: Pediatrics, 2014;134(4):e1104-16 Background Quantifying…
Authors: Harrison L, Gibb DM, Fiscus S, Saïdi Y, Nastouli E, Harper L, Compagnucci A, Babiker A, Melvin A, Tudor-Williams G and the PENPACT 1 (PENTA 9/PACTG 390) Study Team.…
Authors: The PENPACT-1 (PENTA 9 / PACTG 390) Study Team. Published in: Lancet Infectious Diseases. April: 2011, 273-283 Background Children with HIV will be on antiretroviral therapy (ART) longer than adults, and therefore the…
PENTA and IMPAACT: A phase II/III randomised, open-label trial of combination antiretroviral regimens and treatment-switching strategies in HIV-1-infected antiretroviral naïve children Published in: XVIII International AIDS Conference, 22nd July 2010,…